200 related articles for article (PubMed ID: 7899825)
1. Acute graft-versus-host reaction in SCID mice leads to an abnormal expansion of CD8+ V beta 14+ and a broad inactivation of donor T cells followed by a host-restricted tolerance and a normalization of the TCR V beta repertoire in the chronic phase.
Schneider MK; Grönvik KO
Scand J Immunol; 1995 Apr; 41(4):373-83. PubMed ID: 7899825
[TBL] [Abstract][Full Text] [Related]
2. Severe graft-versus-host disease in SCID mice is associated with a decrease of selective donor cell TCR Vbeta specificities and increased expression of IFN-gamma and IL-4.
Schneider MK; Ekholm F; Grönvik KO
Scand J Immunol; 1997 Aug; 46(2):147-58. PubMed ID: 9583995
[TBL] [Abstract][Full Text] [Related]
3. CD4-CD8-C.B-17 SCID thymocytes enter the CD4+CD8+ stage in the presence of neonatally grafted T cells.
Schneider MK; Grönvik KO
Scand J Immunol; 1998 May; 47(5):466-74. PubMed ID: 9627131
[TBL] [Abstract][Full Text] [Related]
4. CD3+ T cells in severe combined immunodeficiency (SCID) mice. V. Allogeneic T cells engrafted into SCID mice do not induce graft-versus-host disease in spite of the absence of host veto and natural suppressor cell activity.
Tscherning T; Rudolphi A; Reimann J; Claesson MH
Scand J Immunol; 1991 Dec; 34(6):795-801. PubMed ID: 1836277
[TBL] [Abstract][Full Text] [Related]
5. Induction of graft versus host disease in SCID mice by MRL/lpr cell transfer.
Fraziano M; Montesano C; Sammarco I; di Cesare S; Caroleo MC; Mattei M; Cannata S; Poccia F; Bellavia A; Salerno A
Clin Immunol Immunopathol; 1994 Jun; 71(3):265-72. PubMed ID: 8200130
[TBL] [Abstract][Full Text] [Related]
6. CD3+ T cells in severe combined immunodeficiency (scid) mice. IV. Graft-vs.-host resistance of H-2d scid mice to intravenous injection of allogeneic H-2b (C57BL/6) spleen cells.
Claesson MH; Rudolphi A; Tscherning T; Reimann J
Eur J Immunol; 1991 Sep; 21(9):2057-62. PubMed ID: 1832384
[TBL] [Abstract][Full Text] [Related]
7. Endogenous superantigens in allogeneic bone marrow transplant recipients rapidly and selectively expand donor T cells which can produce IFN-gamma.
Jones MS; Riley R; Hamilton BL; Paupe J; Perez D; Levy RB
Bone Marrow Transplant; 1994 Nov; 14(5):725-35. PubMed ID: 7889005
[TBL] [Abstract][Full Text] [Related]
8. CD3+ T cells in severe combined immunodeficiency (scid) mice. II. Transplantation of dm2 lymphoid cells into semi-allogeneic scid mice.
Rudolphi A; Spiess S; Conradt P; Claesson MH; Reimann J
Eur J Immunol; 1991 Jul; 21(7):1591-600. PubMed ID: 1829409
[TBL] [Abstract][Full Text] [Related]
9. Selective engraftment of memory CD4+ T cells with an unusual recirculation pattern and a diverse T cell receptor-V beta repertoire into scid mice.
Reimann J; Rudolphi A; Tscherning T; Claesson MH
Eur J Immunol; 1993 Feb; 23(2):350-6. PubMed ID: 8094671
[TBL] [Abstract][Full Text] [Related]
10. Co-expression of CD8 alpha in CD4+ T cell receptor alpha beta + T cells migrating into the murine small intestine epithelial layer.
Reimann J; Rudolphi A
Eur J Immunol; 1995 Jun; 25(6):1580-8. PubMed ID: 7614985
[TBL] [Abstract][Full Text] [Related]
11. Differences between graft-versus-leukemia and graft-versus-host reactivity. I. Interaction of donor immune T cells with tumor and/or host cells.
Rocha M; Umansky V; Lee KH; Hacker HJ; Benner A; Schirrmacher V
Blood; 1997 Mar; 89(6):2189-202. PubMed ID: 9058744
[TBL] [Abstract][Full Text] [Related]
12. Attenuation of lpr-graft-versus-host disease (GVHD) in MRL/lpr spleen cell-injected SCID mice by in vivo treatment with anti-V beta 8.1,2 monoclonal antibody.
Hosaka N; Nagata N; Miyashima S; Ikehara S
Clin Exp Immunol; 1994 Jun; 96(3):500-7. PubMed ID: 8004820
[TBL] [Abstract][Full Text] [Related]
13. Donor T-Cell Repertoire Profiling in Recipient Lymphoid and Parenchyma Organs Reveals GVHD Pathogenesis at Clonal Levels After Bone Marrow Transplantation in Mice.
Wu Y; Fu J; Wang H; Yu XZ
Front Immunol; 2021; 12():778996. PubMed ID: 34950143
[TBL] [Abstract][Full Text] [Related]
14. Graft-facilitating doses of ex vivo activated gammadelta T cells do not cause lethal murine graft-vs.-host disease.
Drobyski WR; Majewski D; Hanson G
Biol Blood Marrow Transplant; 1999; 5(4):222-30. PubMed ID: 10465102
[TBL] [Abstract][Full Text] [Related]
15. The fate of donor T-cell receptor transgenic T cells with known host antigen specificity in a graft-versus-host disease model.
Dey B; Yang YG; Preffer F; Shimizu A; Swenson K; Dombkowski D; Sykes M
Transplantation; 1999 Jul; 68(1):141-9. PubMed ID: 10428282
[TBL] [Abstract][Full Text] [Related]
16. Biased liver T cell receptor V beta repertoire in a murine graft-versus-host disease model.
Howell CD; Li J; Roper E; Kotzin BL
J Immunol; 1995 Sep; 155(5):2350-8. PubMed ID: 7650370
[TBL] [Abstract][Full Text] [Related]
17. Thymic selection and thymic major histocompatibility complex class II expression are abnormal in mice undergoing graft-versus-host reactions.
Desbarats J; Lapp WS
J Exp Med; 1993 Sep; 178(3):805-14. PubMed ID: 8394404
[TBL] [Abstract][Full Text] [Related]
18. Oligoclonal expansion of CTLs directed against a restricted number of dominant minor histocompatibility antigens in hemopoietic chimeras.
Brochu S; Baron C; Hétu F; Roy DC; Perreault C
J Immunol; 1995 Dec; 155(11):5104-14. PubMed ID: 7594519
[TBL] [Abstract][Full Text] [Related]
19. Development of the immune system in severe combined immunodeficiency mice reconstituted with transferred fetal liver cells.
Wakabayashi A; Eishi Y; Nakamura K
J Med Dent Sci; 1997 Mar; 44(1):21-9. PubMed ID: 9385039
[TBL] [Abstract][Full Text] [Related]
20. Facilitation of parental-strain marrow engraftment by T cells of neonatally-tolerant mice.
Davenport C; George T; Devora GA; Morris MA; Gordon BE; Kumar V; Bennett M
Biol Blood Marrow Transplant; 1997 Dec; 3(6):294-303. PubMed ID: 9502296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
